자궁 매니퓰레이션 기기 시장 : 기회, 성장 촉진요인, 업계 동향 분석 및 예측(2026-2035년)

The Global Uterine Manipulation Devices Market was valued at USD 386.6 million in 2025 and is estimated to grow at a CAGR of 5.5% to reach USD 656.1 million by 2035.

Growth across the uterine manipulation devices industry is driven by the increasing number of minimally invasive gynecological procedures, the rising prevalence of gynecological health conditions, and ongoing technological advancements in surgical device development. Healthcare providers are increasingly adopting advanced uterine manipulation systems to improve surgical precision, procedural efficiency, and patient safety during gynecological interventions. These devices play a critical role in positioning and stabilizing the uterus during laparoscopic and minimally invasive surgeries, helping surgeons achieve improved visibility and greater control throughout procedures. The market is also benefiting from rising demand for outpatient and ambulatory surgical services, where efficient and easy-to-use surgical instruments are becoming increasingly important. In addition, growing awareness regarding minimally invasive treatment options and the increasing incidence of uterine-related disorders are contributing to higher procedure volumes worldwide. Continuous innovation focused on ergonomic device design, improved articulation capabilities, and single-use technologies is further supporting market growth by enhancing clinical performance, reducing complications, and improving workflow efficiency within healthcare facilities.

Uterine manipulation devices are specialized surgical instruments designed to support controlled positioning and movement of the uterus during gynecological procedures. These devices are widely utilized in minimally invasive and laparoscopic surgeries to improve surgical access, procedural accuracy, and overall operating efficiency. Market growth is being strongly supported by the rising number of gynecological surgeries performed globally, combined with the increasing adoption of advanced laparoscopic technologies. The growing prevalence of uterine health disorders and expanding demand for safer and more efficient surgical procedures continue to accelerate the adoption of these devices. In addition, improvements in device functionality, enhanced maneuverability, and greater focus on patient safety are encouraging wider use among healthcare professionals. Advanced uterine manipulation systems also contribute to shorter procedure durations, improved surgical outcomes, and better operational consistency across healthcare settings.

The disposable segment accounted for 62.2% share in 2025 and is projected to reach USD 415.2 million by 2035, expanding at a CAGR of 5.7% during the forecast period. Strong growth within this segment is driven by increasing preference for single-use surgical instruments that support enhanced infection prevention and operational efficiency. Disposable uterine manipulators help eliminate concerns related to cross-contamination while reducing the need for extensive sterilization procedures and equipment maintenance. Healthcare facilities are increasingly prioritizing single-use solutions to comply with strict infection control standards and improve procedural workflow in high-volume surgical environments. In addition, disposable devices offer consistent performance and reliability for every procedure, supporting greater surgical accuracy and minimizing the risk of device-related complications over time.

The total laparoscopic hysterectomy segment held 44.5% share in 2025 and is expected to reach USD 298.9 million through 2035. Growing preference for minimally invasive hysterectomy procedures continues to support strong demand for uterine manipulation devices within this segment. Laparoscopic hysterectomy procedures are increasingly favored due to benefits such as reduced recovery time, shorter hospital stays, and lower postoperative discomfort compared to traditional surgical approaches. Uterine manipulators play an essential role in these procedures by improving visualization and supporting accurate uterine positioning during surgery. Advancements in laparoscopic imaging systems and surgical technologies are also enhancing procedural precision and surgeon control, further encouraging broader adoption of total laparoscopic hysterectomy procedures globally.

North America Uterine Manipulation Devices Market accounted for 33.5% share in 2025. The region continues to lead the market due to strong adoption of minimally invasive gynecological procedures and widespread integration of advanced surgical technologies across healthcare facilities. Hospitals and surgical centers throughout North America increasingly utilize high-performance uterine manipulation devices to improve procedural outcomes and surgical efficiency. The growing use of robotic-assisted gynecological surgeries is further contributing to the demand for technologically advanced manipulation systems capable of supporting precision-based procedures. In addition, favorable reimbursement structures and broad insurance coverage for gynecological surgeries continue to support higher procedural volumes and market expansion across the region.

Key companies operating in the Global Uterine Manipulation Devices Market include Aspen Surgical, B. BRAUN, Bissinger Medizintechnik, CONKIN SURGICAL INSTRUMENTS, CONMED, CooperSurgical, EndoMed Systems, KARL STORZ, Laborie, LSI SOLUTIONS, Peters Surgical, Progressive Medical, Purple Surgical, RICHARD WOLF, and UTAH MEDICAL PRODUCTS. Companies operating in the uterine manipulation devices industry are implementing several strategic initiatives to strengthen their market position and improve their competitive advantage. Leading manufacturers are focusing on product innovation by developing advanced single-use devices, ergonomic designs, and enhanced articulation technologies aimed at improving surgical accuracy and ease of use. Businesses are also increasing investments in research and development activities to introduce minimally invasive surgical solutions that align with evolving clinical requirements. Strategic collaborations with hospitals, ambulatory surgical centers, and healthcare providers are helping companies expand distribution networks and strengthen customer relationships. In addition, market participants are prioritizing regulatory compliance, product quality enhancement, and physician training programs to increase product adoption. Expansion into emerging healthcare markets and continuous technological advancements are further supporting long-term growth opportunities within the uterine manipulation devices market.

Table of Contents

Chapter 1 Research Methodology

• 1.1 Research approach
• 1.2 Quality commitments
  • 1.2.1 GMI AI policy & data integrity commitment
    • 1.2.1.1 Source consistency protocol
• 1.3 Research trail & confidence scoring
  • 1.3.1 Research trail components
  • 1.3.2 Scoring components
• 1.4 Data collection
  • 1.4.1 Partial list of primary sources
• 1.5 Data mining sources
  • 1.5.1 Paid sources
    • 1.5.1.1 Sources, by region
• 1.6 Base estimates and calculations
  • 1.6.1 Base year calculation for any one approach
• 1.7 Forecast model
  • 1.7.1 Quantified market impact analysis
    • 1.7.1.1 Mathematical impact of growth parameters on forecast
• 1.8 Research transparency addendum
  • 1.8.1 Source attribution framework
  • 1.8.2 Quality assurance metrics
  • 1.8.3 Our commitment to trust

Chapter 2 Executive Summary

• 2.1 Industry 3600 synopsis
• 2.2 Key market trends
  • 2.2.1 Regional trends
  • 2.2.2 Product type trends
  • 2.2.3 Application trends
  • 2.2.4 End use trends
• 2.3 CXO perspectives: Strategic imperatives

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing prevalence of gynecological disorders
    • 3.2.1.2 Growing awareness and diagnosis rates
    • 3.2.1.3 Technological advancements in products coupled with rise in surgical procedures
    • 3.2.1.4 Shift toward outpatient and ambulatory surgical settings
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost of advanced uterine manipulation devices and procedures
    • 3.2.2.2 Stringent regulatory requirements and approval processes
  • 3.2.3 Market opportunities
    • 3.2.3.1 Expansion in emerging markets with improving healthcare infrastructure
    • 3.2.3.2 Integration with robotic-assisted and AI-driven surgical platforms
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape (Driven by primary research)
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 Asia Pacific
  • 3.4.4 Latin America
  • 3.4.5 MEA
• 3.5 Technology landscape
  • 3.5.1 Current technological trends
  • 3.5.2 Emerging technologies
• 3.6 Future market trends (Driven by primary research)
• 3.7 Porter's analysis
• 3.8 PESTEL analysis
• 3.9 Pricing analysis, 2025
• 3.10 Customer insights (Driven by primary research)
• 3.11 Start-up scenarios (Driven by primary research)
• 3.12 Impact of AI & generative AI on the market
• 3.13 Investment & funding analysis
• 3.14 Gap analysis

Chapter 4 Competitive Landscape, 2025

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis (Driven by primary research)
  • 4.3.1 Global
  • 4.3.2 North America
  • 4.3.3 Europe
  • 4.3.4 Asia Pacific
• 4.4 Competitive positioning matrix
• 4.5 Competitive analysis of major market players
• 4.6 Key developments
  • 4.6.1 Mergers & acquisitions
  • 4.6.2 Partnerships & collaborations
  • 4.6.3 New product launches
  • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product Type, 2022 - 2035 ($ Mn)

• 5.1 Key trends
• 5.2 Disposable
• 5.3 Reusable

Chapter 6 Market Estimates and Forecast, By Application, 2022 - 2035 ($ Mn)

• 6.1 Key trends
• 6.2 Total laparoscopy hysterectomy (TLH)
• 6.3 Laparoscopic supracervical hysterectomy (LSH)
• 6.4 Laparoscopically assisted vaginal hysterectomy (LAVH)
• 6.5 Other applications

Chapter 7 Market Estimates and Forecast, By End Use, 2022 - 2035 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals
• 7.3 Gynecology clinics
• 7.4 Ambulatory surgery centers

Chapter 8 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE

Chapter 9 Company Profiles

• 9.1 Aspen Surgical
• 9.2 B. BRAUN
• 9.3 Bissinger Medizintechnik
• 9.4 CONKIN SURGICAL INSTRUMENTS
• 9.5 CONMED
• 9.6 CooperSurgical
• 9.7 EndoMed Systems
• 9.8 KARL STORZ
• 9.9 Laborie
• 9.10 LSI SOLUTIONS
• 9.11 Peters Surgical
• 9.12 Progressive Medical
• 9.13 Purple Surgical
• 9.14 RICHARD WOLF
• 9.15 UTAH MEDICAL PRODUCTS